TrialEmerging microbes & infections2023

Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial.

Lairun Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.